CoChat

Metabotropic glutamate receptors: Synaptic modulators and therapeutic targets for neurologic disease

Benarroch, Eduardo E. · 2008 · Neurology
Cited by 56

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

AC= : adenylyl cyclase; DAG= : diacylglycerol; FMRP= : fragile X mental retardation protein; FXS= : fragile X syndrome; G= : guanine; GPCR= : guanine nucleotide binding protein coupled receptor; GPe= : external segment of the globus pallidus; GPi= : internal segment of the globus pallidus; IP3= : inositol triphosphate; LTD= : long-term depression; LTP= : long-term potentiation; mGluR= : metabotropic glutamate receptor; PKC= : protein kinase C; PLC= : phospholipase C; SNc= : substantia nigra pars compacta; SNr= : substantia nigra pars reticulata; STN= : subthalamic nucleus; SWD= : spike-and-wave discharges. Glutamate is the primary excitatory neurotransmitter in the CNS and acts via two main classes of receptors: ionotropic and metabotropic. Whereas ionotropic receptors are responsible for fast excitatory synaptic transmission, metabotropic glutamate receptors (mGluRs) have an important role in synaptic modulation throughout the CNS. Different subtypes of mGluRs regulate neuronal excitability, synaptic plasticity, neurotransmitter release, and glial functions, which are important for brain development and mechanisms of learning, injury, and neuroprotection.1–8 Not surprisingly, mGluRs have been implicated in the pathophysiology of several neurologic and psychiatric disorders, including hypoxic injury, epilepsy, Parkinson disease, Alzheimer disease, pain, anxiety, schizophrenia, and drug addiction. The development of selective non-competitive allosteric modulators of different subtypes of mGluRs allows elucidating the physiologic role of these receptors and their potential as therapeutic targets in neurologic disorders.9–11 This brief review focuses on the synaptic effects of mGluRs in some representative circuits and the potential clinical and therapeutic implications. Several publications provide a comprehensive coverage of these and related topics.1,3,5,8–16 The metabotropic receptors (mGluRs) are guanine nucleotide binding (G)-protein coupled receptors (GPCRs) that consist of dimers of subunits with seven transmembrane domains.1,2 There are eight subtypes of mGluRs that are classified, according to their structure, transduction mechanisms, and pharmacology into group I (mGluR1 and mGluR5), group II (mGlu2 and mGlu3), and group III (mGluR4, mGluR6, mGluR7, and mGluR8) receptors1–3 (table 1). Some of these receptors include several isoforms. View this table: Table 1 Overview of metabotropic glutamate receptors Group I receptors (mGluR1 and mGluR5) are positively coupled to phospholipase C, and trigger calcium (Ca2+) release from the endoplasmic reticulum and activation of protein kinase C. These receptors also potentiate l-type Ca2+ channels and inhibit K+ channels. Type I mGluRs may also act independently of G proteins to activate transducing cascades that trigger phosphorylation of …

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1212/01.wnl.0000306315.03021.2a

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 56

Metadata

Authors
Benarroch, E. E.
Venue
Neurology
Published
2008-03-18
Volume
70
Issue
12
Pages
964-968
ISSN
  • 0028-3878 (ISSN-L)
  • 1526-632X
OpenAlex
W2098673651
Cited by
56
References
3
FWCI
1.55
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Metabotropic glutamate receptors: Synaptic modulators and therapeutic targets for neurologic disease. https://app.cochat.ai/papers/10.1212/01.wnl.0000306315.03021.2a
The paper
Benarroch, E. E. (2008). Metabotropic glutamate receptors: Synaptic modulators and therapeutic targets for neurologic disease. Neurology. https://doi.org/10.1212/01.wnl.0000306315.03021.2a

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.